Search
GSK-239512
go.drugbank.com/drugs/DB15120InvestigationalGSK-239512 is under investigation in clinical trial NCT00474513 (An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.).
Fosmanogepix
go.drugbank.com/drugs/DB15183InvestigationalFosmanogepix is under investigation in clinical trial NCT03604705 (An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia).
HCV-086
go.drugbank.com/drugs/DB05884ExperimentalHCV-086 is a small molecule antiviral designed to block an enzyme required for the replication of the hepatitis C virus.
Bufexamac
go.drugbank.com/drugs/DB13346ApprovedWithdrawnThe use of bufexamac has been discontinued in Canada and the United States, which may be due to undetermined clinical efficacy and a high prevalence of contact sensitization [A32822].
Etretinate
go.drugbank.com/drugs/DB00926ApprovedWithdrawnEtretinate was taken off the market in Canada in 1996 and America in 1998 due to the risk of birth defects. Etretinate is now used to treat T-cell lymphomas.
Methylcellulose
go.drugbank.com/drugs/DB11228ApprovedInvestigationalThe Degree of Substitution (DS) of a given form of methyl cellulose is defined as the average number of substituted hydroxyl groups per glucose with a theoretical maximum of 3, however more typical values
PRG-A01
go.drugbank.com/drugs/DB18613InvestigationalPRG-A01 is a novel inhibitor of Cu, Zn-superoxide dismutase (SOD1) misfolding and aggregation.
Cefoselis
go.drugbank.com/drugs/DB19513ExperimentalCefoselis has a monoisotopic molecular weight of 522.11 Da.
Elisidepsin
go.drugbank.com/drugs/DB19522ExperimentalElisidepsin has a monoisotopic molecular weight of 1476.93 Da.
Cargutocin
go.drugbank.com/drugs/DB19643ExperimentalCargutocin has a monoisotopic molecular weight of 915.48 Da.